Fernando
Bermejo San José
Publicacións nas que colabora con Fernando Bermejo San José (2)
2022
-
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
The Lancet Gastroenterology and Hepatology, Vol. 7, Núm. 2, pp. 128-140
-
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
The Lancet Gastroenterology and Hepatology, Vol. 7, Núm. 2, pp. 118-127